Hallucinogens Flashcards
What are hallucinogens
Psychoactive agents that causes changes in perception
What systems do hallucinogen drugs alter
Changes function of monoaminergic (serotonin) or glutamatergic systems
Catecholamines
Dopamine, Noradrenaline, and adrenaline
Monoamines
Serotonin
What are the 4 classes of hallucinogens
Classical Psychedelics
Dissociative agents
Deliriants
Oneirogens
What are Classical Psychedelics
Drugs that cause perception-altering psychedelic effects
Sensory Distortion
What are some examples of Classical Psychedelics
What is the mechanism
Examples: LSD, Psilocybin, DMT
Mechanism: Serotonin 5HT2a Receptor
Who discovered LSD, how?
Albert Hofmann was trying to create a more stable pure ergot (which were produced by fungus that grow on rye and are used as vasoconstrictor to treat migraines)
Accidental made LSD 25
What is LSD
Classical psychedelic that is a partial agonist with a high affinity for 5HT-2a receptors
How do we test that 5HT-2a activation causes hallucinations
Testing mice
Transgenic mouse models lack 5HT2a receptors
Wild type mouse models have 5HT2a receptors
When given LSD the wild type will show hallucinogenic like behaviour in the form of head bobs
The transgenic mouse models do not show such results
What is the mechanism behind 5HT-2a agonists?
Why are not all of these agonists hallucinogenic
Biased agonism
LSD (Gq) activates phospholipase C resulting in hallucinogenic effects
LHM activates beta-arresting signalling resulting in non-hallucinogenic effects
Ketanserin
5HT-2a antagonist blocks hallucinogenic effect of LSD
What is HPPD
Hallucinogenic persisting perception disorder
Distressing visual hallucinations that appear following drug use and even after drug is cleared from system
Relation between LSD and tolerance
Taking LSD can lead to downregulation of specifically 5-HT receptors causing tolerance
Thus, if you were to take more LSD or other hallucinogens acting at serotonin receptors they would be less effective
Psilocybin
Prodrug converted from psilocybin –> psilocin
Partial agonist with lower affinity for 5HT-2a (Hallucinations)
And grater affinity at 5HT-2b and 5HT-2c